LOW DOSE (4.5 MG/KG) OF THYMOGLOBULIN IS EFFECTIVE TO CONTROL T CELLS BUT NOT B CELLS AND CD56DIMCD57+, CD56DIMNKG2A+ NATURAL KILLER CELLS RESULTING IN DE NOVO DONOR-SPECIFIC ANTIBODY FORMATION AND ACUTE REJECTION IN NON-SENSITIZED LIVING DONOR KIDNEY RECIPIENTS WITH EARLY STEROID WITHDRAWAL. Issue 3 (September 2020)